Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",19701,1430,1.08 [1.01-1.16],0.0340996157861964
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,19298,3524,1.08 [1.03-1.13],0.0013028141879853
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),19264,3565,1.05 [1.01-1.10],0.0289213580500108
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,19701,1187,1.10 [1.02-1.19],0.0173436413634222
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,16551,401,1.17 [1.02-1.34],0.0213953131455848
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,19918,1404,1.09 [1.02-1.18],0.0136971366810068
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,18660,389,1.15 [1.01-1.32],0.0400441800114949
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",7208,827,0.90 [0.81-0.99],0.0244150033688327
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Melanocytic naevi of trunk,20048,67,1.53 [1.11-2.11],0.009437259633907
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,19449,2939,1.07 [1.01-1.12],0.012122503858985
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,18639,60,1.55 [1.10-2.17],0.0123328627348768
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,19769,1190,1.21 [1.12-1.31],1.444210540344857e-06
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",19857,240,0.71 [0.59-0.85],0.0002034741235846
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,19843,1195,1.12 [1.04-1.21],0.0039202329182497
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,17001,1166,1.13 [1.04-1.22],0.0025256898917803
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,17166,3923,1.06 [1.01-1.11],0.0086788943951678
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,18732,5489,1.04 [1.00-1.08],0.0290021314597719
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,19371,1841,1.08 [1.01-1.15],0.0196987936777751
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,19172,512,0.88 [0.78-0.99],0.0312281263699866
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",19956,267,0.80 [0.68-0.95],0.010632697239938
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Aortic aneurysm,18906,316,0.85 [0.73-0.99],0.0346609475579297
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,DVT of lower extremities,18730,293,0.83 [0.71-0.98],0.024714333773804
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",19958,165,1.30 [1.06-1.60],0.0115612839564376
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),18802,365,0.83 [0.72-0.96],0.0109547324092548
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",17282,1216,1.13 [1.05-1.22],0.0014803029709407
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,Smoking dependency,19633,994,1.10 [1.01-1.20],0.0337821585326453
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",17296,1230,1.08 [1.00-1.17],0.0445602703969288
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,18989,35,1.79 [1.15-2.79],0.009561693102349
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,20063,67,1.48 [1.07-2.04],0.017051652945112
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,20055,59,1.51 [1.07-2.12],0.0180098739282857
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,19107,153,0.76 [0.61-0.95],0.0157728360038761
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,19955,101,1.32 [1.02-1.72],0.037662112203595
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Allergic asthma (mode),12445,85,1.44 [1.09-1.92],0.0114626148954775
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",13542,1506,1.11 [1.03-1.19],0.0041238220122636
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",13847,1487,1.10 [1.03-1.18],0.0064676663282342
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Bronchiectasis,16809,442,1.21 [1.07-1.37],0.0030893008652618
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",16430,63,1.45 [1.04-2.01],0.027786861603988
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,19097,2730,1.09 [1.03-1.15],0.0010687761308399
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",19819,1387,1.10 [1.02-1.18],0.0123522183300873
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,18205,5230,1.07 [1.03-1.11],0.0002780299361862
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Emphysema,16747,380,1.18 [1.03-1.36],0.0160421299469245
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Influenza and pneumonia,19841,2156,1.08 [1.02-1.15],0.0066127446032206
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Later onset COPD,19609,1286,1.10 [1.02-1.18],0.0172319641743359
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Other diseases of pleura,19817,2281,1.07 [1.01-1.13],0.0223943693751703
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,19952,1463,1.11 [1.04-1.19],0.0030818178779041
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",19599,1914,1.09 [1.03-1.16],0.0057868074794638
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Respiratory insufficiency,12421,61,1.64 [1.19-2.27],0.0025272828894475
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Cholelithiasis,19071,898,1.11 [1.01-1.21],0.0261259508168955
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Chronic pancreatitis,18220,47,0.62 [0.42-0.94],0.0234236379429591
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Crohn's disease NAS,18542,63,1.43 [1.03-2.00],0.0333838628961218
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",19479,1306,1.09 [1.02-1.18],0.0173756288208659
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,12873,95,1.34 [1.02-1.75],0.0364592670858923
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,18052,287,0.82 [0.70-0.97],0.017909694724523
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",18036,271,1.21 [1.02-1.42],0.0249022947072636
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,16746,68,0.67 [0.48-0.94],0.0219596584735182
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,17699,5533,1.04 [1.01-1.08],0.0247880004941013
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,16253,6923,1.04 [1.00-1.07],0.0347743067729163
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,16805,127,1.28 [1.02-1.62],0.0360928658254308
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,12824,658,1.15 [1.03-1.27],0.0117364929537513
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",19983,652,1.14 [1.02-1.26],0.0169154267469113
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,16673,69,1.54 [1.12-2.11],0.0079523161545204
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",19930,464,1.16 [1.02-1.31],0.0205387044483483
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,16739,61,1.74 [1.25-2.42],0.0010894149714836
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",17823,1145,1.11 [1.03-1.21],0.0071986629436801
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,13949,1783,1.08 [1.01-1.15],0.0254787725430864
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,19740,430,1.18 [1.04-1.35],0.0101438215241974
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,19941,459,1.16 [1.02-1.31],0.019428654276128
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,20048,58,1.71 [1.22-2.40],0.0017710146123409
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,15658,744,1.11 [1.00-1.22],0.044179392396366
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,14847,2681,1.10 [1.04-1.15],0.0005517595657179
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,12876,710,1.11 [1.01-1.23],0.0366809542056057
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,12637,471,1.18 [1.05-1.34],0.0076381392261434
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,16849,245,1.24 [1.05-1.47],0.0131717171064916
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",20052,62,1.57 [1.13-2.17],0.0072715856690709
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],19397,87,1.40 [1.06-1.86],0.0176007952206942
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,19791,267,1.18 [1.00-1.39],0.0458552146423496
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,8145,82,1.37 [1.03-1.83],0.0305043846394449
